Aleksi Tornio - UTU Research Portal

Aleksi Tornio

- Associate Professor,
Institute of Biomedicine (Faculty of Medicine)

aleksi.tornio@utu.fi

+358 29 450 4608

+358 50 476 5715

Kiinamyllynkatu 10

Turku

ORCID identifier: https://orcid.org/0000-0001-5713-5692

Areas of expertise

Clinical Pharmacology; Pharmacokinetics; Drug-drug interactions; Pharmacogenetics

Publications

5 of 9

Performance of plasma coproporphyrin I and III as OATP1B1 biomarkers in humans (2021)
- Clinical Pharmacology and Therapeutics
Neuvonen Mikko, Tornio Aleksi, Hirvensalo Päivi, Backman Janne T, Niemi Mikko
(A1 Refereed original research article in a scientific journal)
Sex-Based Outcomes After Coronary Artery Bypass Grafting (2021)
- Annals of Thoracic Surgery
Kytö Ville, Sipilä Jussi, Tornio Aleksi, Rautava Päivi, Gunn Jarmo
(A1 Refereed original research article in a scientific journal)
Effect of High-Dose Esomeprazole on CYP1A2, CYP2C19, and CYP3A4 Activities in Humans: Evidence for Substantial and Long-lasting Inhibition of CYP2C19 (2020)
- Clinical Pharmacology and Therapeutics
Taavi J. K. Kaartinen, Aleksi Tornio, Tuija Tapaninen, Terhi Launiainen, Nina Isoherranen, Mikko Niemi, Janne T. Backman
(A1 Refereed original research article in a scientific journal)
Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate Rosuvastatin (2020)
- Clinical and Translational Science
Lehtisalo M, Keskitalo JE, Tornio A, Lapatto-Reiniluoto O, Deng F, Jaatinen T, Viinamaki J, Neuvonen M, Backman JT, Niemi M
(A1 Refereed original research article in a scientific journal)
Identification of Glycochenodeoxycholate 3-O-glucuronide and Glycodeoxycholate 3-O-glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers (2020)
- Clinical Pharmacology and Therapeutics
Neuvonen M, Hirvensalo P, Tornio A, Rago B, West M, Lazzaro S, Mathialagan S, Varma M, Cerny MA, Costales C, Ramanathan R, Rodrigues AD, Niemi M
(A1 Refereed original research article in a scientific journal)
Placental transporter-mediated drug interactions and offspring congenital anomalies (2020)
- British Journal of Clinical Pharmacology
Maria Ellfolk, Aleksi Tornio, Mikko Niemi, Maarit K. Leinonen, Anna‐Maria Lahesmaa‐Korpinen, Heli Malm
(A1 Refereed original research article in a scientific journal)
UGT1A3 and Sex Are Major Determinants of Telmisartan Pharmacokinetics-A Comprehensive Pharmacogenomic Study (2020)
- Clinical Pharmacology and Therapeutics
Hirvensalo P, Tornio A, Launiainen T, Paile-Hyvarinen M, Tapaninen T, Neuvonen M, Backman JT, Niemi M
(A1 Refereed original research article in a scientific journal)
Clinical Studies on Drug-Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation (2019)
- Clinical Pharmacology and Therapeutics
Tornio A, Filppula AM, Niemi M, Backman JT
(A2 Refereed review article in a scientific journal )
Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In Humans (2019)
- Drug Metabolism and Disposition
Itkonen MK, Tornio A, Neuvonen M, Neuvonen PJ, Niemi M, Backman JT
(A1 Refereed original research article in a scientific journal)
Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel (2019)
- Clinical Pharmacology and Therapeutics
Itkonen MK, Tornio A, Lapatto-Reiniluoto O, Neuvonen M, Neuvonen PJ, Niemi M, Backman JT
(A1 Refereed original research article in a scientific journal)